Jason Blum and James Wan dissect horror's box office surge and Hollywood's Backrooms obsession

Jason Blum and James Wan, the leaders behind Blumhouse and Atomic Monster, walked onto IndieWire's "Screen Talk" podcast to break down a single, practical question: why horror is suddenly winning like it has leverage in a wider market. The episode centers on their recent “victory laps” with this year's hottest horrors, including Blum and Wan discussing specific titles like “Backrooms” and “Obsession,” plus broader topics like box office performance and why Hollywood keeps orbiting the genre.

That matters because horror has always been a risk profile, but this year it is reading like a portfolio strategy. When Blumhouse and Atomic Monster talk about “Backrooms,” “Obsession,” box office, and the “Hollywood’s horror craze,” they are not just celebrating. They are effectively mapping what studios, streamers, and investors are willing to bet on right now, and why the winning formula is repeating.

To understand the signal, you have to know how horror usually behaves in the industry. It tends to be built for efficiency: smaller budgets relative to tentpoles, faster pivots in marketing, and a story structure that can travel between theatrical and streaming windows. That does not mean horror is low stakes. It means it can be high reward when the package lands. Blumhouse is the clearest example of that approach at scale, and Atomic Monster has become a parallel center of gravity when it comes to mainstream visibility for horror brands. So when the two of them talk box office and “horror craze,” the subtext for executives is about matching creative bets to financial reality.

The episode also highlights a modern dynamic: horror is no longer just a subculture product. IndieWire frames it as a “Hollywood’s horror craze,” which is a reminder that the industry has learned how to systematize audience demand. When Hollywood repeatedly turns toward one genre, it affects everything downstream. Development slates shift. Talent deals get re-priced. Production schedules tighten. Marketing budgets can balloon because the risk is now perceived as lower, even if the creative uncertainty is still real. In other words, when horror is hot, the entire pipeline starts moving like it is on rails.

For decision-makers thinking about second-order effects, the Blumhouse and Atomic Monster lens is instructive. Their partnership positions them as both brand operators and content engineers. That blend tends to change how deals get discussed. If box office performance supports the hypothesis that the audience is actively seeking these stories, then boards and finance teams can justify additional runway for similar development, even when the original project had no guarantee of being “this year's hottest horror.” That is how a “victory lap” becomes a system: success in one title lowers the perceived risk, which increases spending on the next round of experiments.

There is also a structural point about how studios and investors react to genre momentum. Big swings in theatrical performance often drive faster decision cycles than long-cycle industries like scripted prestige drama. Horror offers a template for rapid learning. If marketing traction appears quickly, it can inform production decisions, release timing, and distribution strategy. Even the conversation format matters: a podcast discussion allows Blum and Wan to move from titles to mechanics, from creative choices to performance indicators, without waiting for a quarterly earnings call.

None of this means regulators are directly involved in the horror “craze” itself in the way they would be for, say, banking or telecom. But for executives, regulatory context still matters because it shapes the boundaries of what can be financed and distributed smoothly. Ratings compliance, platform requirements, and content labeling rules affect distribution logistics and marketing claims. Those constraints often become more visible when a genre is scaling fast. When horror becomes mainstream, it gets more scrutiny, more cataloging, and more cross-market distribution pressure. That can raise operational overhead while also expanding the potential audience.

So what should peers in similar roles take away from Blum and Wan's “Screen Talk” breakdown? First, horror momentum is not only creative. It is commercial discipline plus audience literacy. Second, “victory laps” are a signal that investors and executives already see the genre as a repeatable engine, not a novelty. Third, when Hollywood declares a genre craze, the real question for boards and operators is how quickly you can convert demand into development throughput without letting creative constraints or distribution realities choke execution. In a market where attention moves fast, the winners are the teams that can explain, measure, and replicate what works, one title at a time.